These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8798405)

  • 1. Role of the low density lipoprotein (LDL) receptor pathway in the metabolism of chylomicron remnants. A quantitative study in knockout mice lacking the LDL receptor, apolipoprotein E, or both.
    Ishibashi S; Perrey S; Chen Z; Osuga Ji; Shimada M; Ohashi K; Harada K; Yazaki Y; Yamada N
    J Biol Chem; 1996 Sep; 271(37):22422-7. PubMed ID: 8798405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular localization and metabolism of chylomicron remnants in the livers of low density lipoprotein receptor-deficient mice and apoE-deficient mice. Evidence for slow metabolism via an alternative apoE-dependent pathway.
    Mortimer BC; Beveridge DJ; Martins IJ; Redgrave TG
    J Biol Chem; 1995 Dec; 270(48):28767-76. PubMed ID: 7499399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid initial removal of chylomicron remnants by the mouse liver does not require hepatically localized apolipoprotein E.
    Yu KC; Jiang Y; Chen W; Cooper AD
    J Lipid Res; 2000 Nov; 41(11):1715-27. PubMed ID: 11060341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.
    Herz J; Qiu SQ; Oesterle A; DeSilva HV; Shafi S; Havel RJ
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4611-5. PubMed ID: 7753850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
    Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4431-5. PubMed ID: 8183926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of gene-manipulated models to study the physiology of lipid transport.
    Mortimer BC; Martins I; Zeng BJ; Redgrave TG
    Clin Exp Pharmacol Physiol; 1997; 24(3-4):281-5. PubMed ID: 9131298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL receptor in the removal of chylomicron remnants in the mouse in vivo.
    Choi SY; Fong LG; Kirven MJ; Cooper AD
    J Clin Invest; 1991 Oct; 88(4):1173-81. PubMed ID: 1918372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice.
    Martins IJ; Hone E; Chi C; Seydel U; Martins RN; Redgrave TG
    J Lipid Res; 2000 Feb; 41(2):205-13. PubMed ID: 10681404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway.
    Crawford SE; Borensztajn J
    J Lipid Res; 1999 May; 40(5):797-805. PubMed ID: 10224148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo.
    Rensen PC; Herijgers N; Netscher MH; Meskers SC; van Eck M; van Berkel TJ
    J Lipid Res; 1997 Jun; 38(6):1070-84. PubMed ID: 9215536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
    Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraceptive steroids increase hepatic uptake of chylomicron remnants in healthy young women.
    Berr F; Eckel RH; Kern F
    J Lipid Res; 1986 Jun; 27(6):645-51. PubMed ID: 3746133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
    Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
    Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.
    Hussain MM; Innerarity TL; Brecht WJ; Mahley RW
    J Biol Chem; 1995 Apr; 270(15):8578-87. PubMed ID: 7721759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.
    Magoori K; Kang MJ; Ito MR; Kakuuchi H; Ioka RX; Kamataki A; Kim DH; Asaba H; Iwasaki S; Takei YA; Sasaki M; Usui S; Okazaki M; Takahashi S; Ono M; Nose M; Sakai J; Fujino T; Yamamoto TT
    J Biol Chem; 2003 Mar; 278(13):11331-6. PubMed ID: 12509421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.
    Kita T; Goldstein JL; Brown MS; Watanabe Y; Hornick CA; Havel RJ
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3623-7. PubMed ID: 6285353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple processes are involved in the uptake of chylomicron remnants by mouse peritoneal macrophages.
    Fujioka Y; Cooper AD; Fong LG
    J Lipid Res; 1998 Dec; 39(12):2339-49. PubMed ID: 9831622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.